Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2008
12/31/2008EP1113810B1 Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding
12/31/2008EP1040119B1 Hemiasterlin analogs
12/31/2008EP1032672B1 Dna19355 polypeptide, a tumor necrosis factor homolog
12/31/2008EP1028751B1 Methods and compositions comprising glycoprotein glycoforms
12/31/2008CN101336249A 新型肽化合物 Novel peptide compounds
12/31/2008CN101336244A 9-membered heterobicyclic compounds as inhibitors of protein kinases
12/31/2008CN101334356A Gas sensors
12/31/2008CN101333531A CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof
12/31/2008CN101333530A Apoptosis-associated gene and medicaments for treating leucocythemia using the gene as target
12/31/2008CN101333524A Small molecule noncoding RNA gene hsa-mir-101 and antineoplastic use thereof
12/31/2008CN101333515A Supernatant cultured by DCIK cell and use thereof
12/31/2008CN101333256A Human antibodies that bind human il-12 and methods for producing
12/31/2008CN101333252A Decorin gene capable of restraining tumour cell from growing and transferring, preparation method and application thereof
12/31/2008CN101333244A Protein purification by ion exchange chromatography
12/31/2008CN101333242A New antineoplastic compounds of triterpenoid saponin
12/31/2008CN101333239A Anti-glioma compounds of triterpenoid saponin extracted from ardipusilloside
12/31/2008CN101333238A Triterpene compounds separated from seed of cowherb of Chinese traditional medicine and uses thereof
12/31/2008CN101333237A Oligonucleotide with breast carcinoma treating function
12/31/2008CN101333236A Method for preparing clitocine and applications in antineoplastic medicaments
12/31/2008CN101333235A Nucleoside derivates with ethynyl and fluor substituted glycosyl
12/31/2008CN101333215A Method for synthesizing sunitinib alkali
12/31/2008CN101333205A Baicalin piperazine of cyclin-dependent kinases and preparation method thereof
12/31/2008CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
12/31/2008CN101333187A Novel PI3K enzyme inhibitors and uses thereof
12/31/2008CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof
12/31/2008CN101332301A Antineoplastic composition and use thereof
12/31/2008CN101332300A Dosages for treatment with anti-egfr antibodies
12/31/2008CN101332299A Dosages for treatment with anti-egfr antibodies
12/31/2008CN101332295A Enteric-coated glucosinolates and beta-thioglucosidases
12/31/2008CN101332277A Preparation method of emergency liquor for raising the whole blood
12/31/2008CN101332276A Traditional Chinese medicine for treating uterus tumour
12/31/2008CN101332235A Magnolia bark and processing technique
12/31/2008CN101332206A Anticancer composition loaded with anti-metabolism and synergist thereof
12/31/2008CN101332204A Anticancer composition containing phosphoinositide 3-kinase inhibitor and topology enzyme inhibitor
12/31/2008CN101332201A Anticancer composition containing irinotecan
12/31/2008CN101332199A Anticancer composition containing phosphoinositide 3-kinase inhibitor and topology enzyme inhibitor
12/31/2008CN101332198A Pharmaceutical use of 6-aryl-3-substituted carbonyl pyridine compound
12/31/2008CN101332185A SiRNA liposome preparation
12/31/2008CN101332181A Anticancer composition containing irinotecan
12/31/2008CN101332179A Anticancer composition containing lurtotecan
12/31/2008CN101332175A Preparation technique of protein microsphere suppository
12/31/2008CN101332169A Preparation method of thymopentin formulation for nasal administration
12/31/2008CN100447244C BAFF receptor (BCMA), immunoregulatory agent
12/31/2008CN100447160C Modified acacia and use thereof
12/31/2008CN100447159C Antibodies to ED-8 domain of fibronectin, their construction and uses
12/31/2008CN100447158C Neutralizable epitope of HGF and neutralizing antibody binding to the same
12/31/2008CN100447143C Compounds and compositions as inhibitors of receptor tyrosine kinase activity
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446811C Composition comprising immunogenic microparticles
12/31/2008CN100446802C Crude drug for preventing tumor metastasis
12/31/2008CN100446795C Medicinal composition for treating leukaemia
12/31/2008CN100446776C Superoxide anion decomposing agent
12/31/2008CN100446761C Application of scutellaria root extract in preparation of anti esophageal cancer medicine
12/31/2008CA2704282A1 Quinazolinone compounds and methods of use thereof
12/31/2008CA2692263A1 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
12/31/2008CA2692191A1 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
12/31/2008CA2691888A1 New chemical compounds
12/31/2008CA2691745A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
12/31/2008CA2691580A1 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
12/31/2008CA2691510A1 Compositions and methods of treating cancer
12/31/2008CA2691200A1 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors
12/31/2008CA2691166A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
12/31/2008CA2690888A1 Cancer therapeutic composition comprising antibody against peptide encoded by exon-17 site of periostin
12/31/2008CA2690799A1 Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
12/31/2008CA2690782A1 Compositions and methods for treatment of cancer
12/31/2008CA2690378A1 Phthalazine compounds, compositions and methods of use
12/31/2008CA2690244A1 Metap-2 inhibitor polymersomes for therapeutic administration
12/31/2008CA2690192A1 Imidazopyridinyl thiazolyl histone deacetylase inhibitors
12/31/2008CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/31/2008CA2690064A1 Benzimidazole amido derivatives as kinase inhibitors
12/31/2008CA2689299A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
12/31/2008CA2686225A1 Solubilized formulation of docetaxel without tween 80
12/30/2008US7470792 Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
12/30/2008US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions
12/30/2008US7470721 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
12/30/2008US7470717 Indazole derivatives
12/30/2008US7470714 GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470709 Benzimidazole quinolinones and uses thereof
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470698 Adenosine A3 receptor modulators
12/30/2008US7470697 E.g.,1-(2-(dimethylamino)ethyl)-3-(4-fluorophenyl)-1-(5-(2,3,4,5-tetrahydro-2,4-dioxo-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidin-6-yl)pyridin-2-yl)urea; antidiarrhea and -ischemic agents; antidiabetic agents/insulin-resistance; asthma; antiallergens; obesity; autoimmune diseases; reperfusion injuries
12/30/2008US7470695 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
12/30/2008US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent
12/30/2008US7470687 Aryl oximes
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents
12/30/2008US7470510 Methods for diagnosing cancer and determining a susceptibility for developing cancer
12/30/2008US7470428 Compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is
12/30/2008CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
12/30/2008CA2400237C Pluraflavins and derivatives thereof, process for their preparation and use thereof
12/30/2008CA2395652C New derivatives of benzo[b]pyrano[3,2-h]acridin-7-one, process for preparing them, and pharmaceutical compounds containing them
12/30/2008CA2388933C Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases
12/30/2008CA2387873C Nordihydroguaiaretic derivatives for use in treatment of tumors
12/30/2008CA2368767C Protease resistant flint analogs
12/30/2008CA2351703C Novel 4-dedimethylaminotetracycline derivatives
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2294243C Novel cyanoaziridines for treating cancer
12/30/2008CA2253207C Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy
12/30/2008CA2250295C Water soluble paclitaxel prodrugs
1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 2211